Clinical Trial Update: Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an immunomodulatory treatment for interstitial lung disease associated with surfactant-related gene variants; the study is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Interstitial Lung Disease | Phase 2 | Status: NOT_YET_RECRUITING